Astrana Health, Inc. (ASTH) financial statements and ratios from SEC XBRL: revenue $3.2B (TTM), net margin 0.7%, revenue growth 55.6% YoY, P/E 93.2. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $3.18B |
| Revenue (TTM) | $3.2B |
| Net Margin | 0.7% |
| Operating Margin (TTM) | 2.5% |
| Net Debt / EBITDA | 4.4 |
| Revenue Growth (YoY) | 55.6% |
| EPS Growth (YoY) | 114.3% |
| FCF Growth (YoY) | 372.5% |
| P/E Ratio | 93.2 |
| EV / EBITDA | 21.4 |
| Price / Book | 2.57 |
| Price / Sales | 0.66 |
| FCF Yield | 8.3% |
| Altman Z-Score | 2.76 (grey) |
| Industry P/E (Business Services) | 30.0 |
| Sector P/E (Technology) | 34.1 |
ASTH overview · ASTH earnings · ASTH KPIs · ASTH documents · ASTH ownership · ASTH peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.